News
2d
Zacks Investment Research on MSNBristol Myers Loses 19.2% in Six Months: Buy, Sell or Hold?
Shares of this biotech giant have lost 19.2% in the past six months against the industry’s growth of 0.6%. The stock has also ...
LB Pharmaceuticals, which has a schizophrenia medicine headed for late-stage testing, broke one of the longest droughts for ...
PGIM shares how the Jennison Health Sciences Fund weathered Q2 volatility by leaning into undervalued innovators. Discover ...
In September 2025, The FDA approved an injectable extended-release risperidone suspension from Amneal Pharmaceuticals, ...
Detailed price information for Puretech Health Plc ADR (PRTC-Q) from The Globe and Mail including charting and trades.
What it also allows us to do is to develop and deploy significant capital into areas where we think there is the potential ...
SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of ...
Big score for Fenton as a former California-based company plans to grow locally. 2025 Corporate Leadership Awards Join us as we honor outstanding C-Level Executives for their invaluable contributions ...
Bristol-Myers Squibb Company (NYSE:BMY) is one of the top most undervalued low volatility stocks to buy now. On August 25, BMO Capital analyst Evan Seigerman of BMO Capital maintained a Hold rating on ...
The gut contains the largest collection of immune cells in the body. New research at the Buck Institute shows that some of those immune cells travel along the brain/gut axis in a mouse model of ...
NEEDHAM, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results